We are live on
!
Find out more
MCM
McRae Capital Management Portfolio holdings
AUM
$540M
Turnover
8.47%
1-Year Est. Return
15.41%
This Fund
S&P 500
This Quarter
Est. Return
+1.17%
1 Year Est. Return
+15.41%
3 Year Est. Return
+78.2%
5 Year Est. Return
+77.01%
10 Year Est. Return
+368.49%
AUM
$216M
AUM Growth
-$7.9M
(-3.5%)
Cap. Flow
-$8.39M
Cap. Flow
% of AUM
-3.88%
Top 10 Holdings %
Top 10 Hldgs %
41.54%
Holding
102
New
6
Increased
52
Reduced
19
Closed
3
Avg Time Held
1.9
years
Top 10 Avg Time Held
1.8
years
Top 20 Avg Time Held
2.2
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Labcorp
LH
|
+$6.38M |
| 2 |
Medtronic
MDT
|
+$743K |
| 3 |
Pentair
PNR
|
+$649K |
| 4 |
AbbVie
ABBV
|
+$319K |
| 5 |
IBM
IBM
|
+$302K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Travelers Companies
TRV
|
+$9.75M |
| 2 |
Baxter International
BAX
|
+$4.48M |
| 3 |
BXLT
BAXALTA INC COM STK (DE)
BXLT
|
+$4.35M |
| 4 |
Lowe's Companies
LOW
|
+$371K |
| 5 |
Omnicom Group
OMC
|
+$324K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.19% |
| 2 | Technology | 15.51% |
| 3 | Financials | 15.01% |
| 4 | Industrials | 10.76% |
| 5 | Consumer Discretionary | 9.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
76
State Street SPDR S&P 500 ETF Trust
SPY
$806B
| $320K | 0.15% |
1,529
+15
| +1% | +$3.11K |
2013 Q2
12 quarters
|
|
77
CVS Health
CVS
$118B
| $316K | 0.15% |
3,300
| – | – |
2013 Q4
10 quarters
|
|
78
Walt Disney
DIS
$191B
| $310K | 0.14% |
3,173
+100
| +3% | +$10K |
2014 Q4
6 quarters
|
|
79
3M
MMM
$85B
| $298K | 0.14% |
2,033
| – | – |
2013 Q2
12 quarters
|
|
80
Philip Morris
PM
$320B
| $292K | 0.14% |
2,874
| – | – |
2015 Q3
3 quarters
|
|
81
Nike
NKE
$55.1B
| $287K | 0.13% |
5,200
| – | – |
2013 Q2
12 quarters
|
|
82
Honeywell
HON
$67B
| $274K | 0.13% |
2,624
| – | – |
2013 Q4
10 quarters
|
|
83
Bristol-Myers Squibb
BMY
$122B
| $268K | 0.12% |
3,650
| – | – |
2016 Q1
1 quarter
|
|
84
Consolidated Edison
ED
$41.5B
| $267K | 0.12% |
3,316
| – | – |
2015 Q3
3 quarters
|
|
85
United Parcel Service
UPS
$82.9B
| $265K | 0.12% |
2,460
+3
| +0.1% | +$312 |
2016 Q1
1 quarter
|
|
86
J.M. Smucker
SJM
$13.6B
| $258K | 0.12% |
1,695
+95
| +6% | +$12.6K |
2016 Q1
1 quarter
|
|
|
TIF
87
DELISTED
Tiffany & Co.
TIF
| $255K | 0.12% |
4,200
| – | – |
2013 Q2
12 quarters
|
|
88
Kimberly-Clark
KMB
$35.1B
| $252K | 0.12% |
1,835
+60
| +3% | +$7.85K |
2015 Q4
2 quarters
|
|
89
Eli Lilly
LLY
$1.12T
| $244K | 0.11% |
+3,104
| New | +$234K |
2016 Q2
0 quarters
|
|
90
Middlesex Water
MSEX
$1.03B
| $234K | 0.11% |
+5,400
| New | +$200K |
2016 Q2
0 quarters
|
|
91
DELISTED
Paramount Global Class B
PARA
| $230K | 0.11% |
+4,225
| New | +$230K |
2016 Q2
0 quarters
|
|
92
Vanguard S&P 500 ETF
VOO
$1.03T
| $221K | 0.1% |
1,150
| – | – |
2014 Q2
8 quarters
|
|
|
DNY
93
DELISTED
DONNELLEY R R & SONS CO
DNY
| $220K | 0.1% |
13,025
+1,803
| +16% | +$30.5K |
2016 Q1
1 quarter
|
|
|
MENT
94
DELISTED
Mentor Graphics Corp
MENT
| $207K | 0.1% |
+9,737
| New | +$202K |
2016 Q2
0 quarters
|
|
95
Valley National Bancorp
VLY
$7B
| $199K | 0.09% |
21,815
+3,768
| +21% | +$35.3K |
2016 Q1
1 quarter
|
|
|
WMGI
96
DELISTED
Wright Medical Group Inc
WMGI
| $199K | 0.09% |
11,446
-2,044
| -15% | -$37.5K |
2016 Q1
1 quarter
|
|
97
Alcoa
AA
$10.9B
| $140K | 0.06% |
6,267
+1,665
| +36% | +$39K |
2016 Q1
1 quarter
|
|
98
Celldex Therapeutics
CLDX
$2.16B
| $72K | 0.03% |
1,090
+215
| +25% | +$13.6K |
2016 Q1
1 quarter
|
|
99
DELISTED
Yield10 Bioscience, Inc. Common Stock
YTEN
| $11K | 0.01% |
1
| – | – |
2013 Q2
12 quarters
|
|
|
100
Baxter International
BAX
$13.1B
| – | – |
-109,164
| Closed | -$4.48M | – |
|
Similar funds
DF
NQWM
ACM
MLIC
CAM
MWM
WWMSC
VCM
McRae Capital Management's Q2 2016 Portfolio in Review
As of Q2 2016, McRae Capital Management held 102 positions worth $216M, down 3.5% from $224M the previous quarter. Its ten largest holdings account for 42% of the portfolio.
McRae Capital Management withdrew a net $8.39M in Q2 2016, closing 3 positions and reducing 19 holdings. Its most notable exit was Travelers Companies, an estimated $9.75M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 17% a quarter earlier, followed by Technology and Financials.
Against the trend, McRae Capital Management opened a new position in Labcorp worth $6.63M.
- McRae Capital Management's largest Q2 2016 buy was Labcorp: 59,253 shares worth $6.63M.
- McRae Capital Management added most to Medtronic in Q2 2016, an estimated $743K increase.
- McRae Capital Management's biggest Q2 2016 reduction was Lowe's Companies, cutting an estimated $371K.
- McRae Capital Management fully exited Travelers Companies in Q2 2016, selling an estimated $9.75M.
- McRae Capital Management's ten largest holdings make up 42% of its $216M portfolio in Q2 2016.
- McRae Capital Management opened 6 new positions and closed 3 in Q2 2016.
- McRae Capital Management's portfolio value fell 3.5% quarter-over-quarter to $216M.
Based on McRae Capital Management's 13F filing for Q2 2016, filed 2 Aug 2016.